| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.55 | 0.004 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.17 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |